Abstract:The presence of neuritic plaques is a pathological hallmark of Alzheimer's disease (AD). However, the origin of extracellular beta-amyloid peptide (A beta) deposits and the process of plaque development remain poorly understood. The present study attempted to explore plaque pathogenesis by localizing beta-secretase-1 (BACE1) elevation relative to A beta accumulation and synaptic/neuritic alterations in the forebrain, using transgenic mice harboring familial AD (FAD) mutations (5XFAD and 2XFAD) as models. In animals with fully developed plaque pathology, locally elevated BACE1 immunoreactivity (IR) coexisted with compact-like A beta deposition, with BACE1 IR occurring selectively in dystrophic axons of various neuronal phenotypes or origins (GABAergic, glutamatergic, cholinergic or catecholaminergic). Prior to plaque onset, localized BACE1/A beta IR occurred at swollen presynaptic terminals and fine axonal processes. These BACE1/A beta-containing axonal elements appeared to undergo a continuing process of sprouting/swelling and dystrophy, during which extracellular A beta IR emerged and accumulated in surrounding extracellular space. These data suggest that BACE1 elevation and associated A beta overproduction inside the sprouting/dystrophic axonal terminals coincide with the onset and accumulation of extracellular amyloid deposition during the development of neuritic plaques in transgenic models of AD. Our findings appear to be in harmony with an early hypothesis that axonal pathogenesis plays a key or leading role in plaque formation.

Delta- and Beta-Secretases Crosstalk Amplifies the Amyloidogenic Pathway in Alzheimer's Disease

Delta- and beta- secretases crosstalk amplifies the amyloidogenic pathway in Alzheimer’s disease

Delta-secretase Cleaves Amyloid Precursor Protein and Regulates the Pathogenesis in Alzheimer's Disease

Δ-Secretase-cleaved Tau Stimulates Aβ Production Via Upregulating STAT1-BACE1 Signaling in Alzheimer's Disease.

Spatiotemporal Activation Of The C/Ebp Beta/Delta-Secretase Axis Regulates The Pathogenesis Of Alzheimer'S Disease

A GPCR/secretase Complex Regulates Β- and Γ-Secretase Specificity for Aβ Production and Contributes to AD Pathogenesis

[P4–126]: Δ‐secretase–cleaved TAU STIMULATES Aβ PRODUCTION VIA ACTIVATING STAT1‐BACE1 PATHWAY IN ALZHEIMER's DISEASE

TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer’s disease pathologies

Delta-secretase Triggers Alzheimer's Disease Pathologies in Wild-Type Happ/hmapt Double Transgenic Mice.

CCAAT-Enhancer Binding Protein-beta (C/EBPP) Regulates Deltasecretase Expression, Mediating the Pathogenesis in Alzheimer's Disease

C/EBPβ Regulates Delta-Secretase Expression and Mediates Pathogenesis in Mouse Models of Alzheimer’s Disease

Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease

Secretases Related to Amyloid Precursor Protein Processing

Asparagine Endopeptidase Cleaves Amyloid Precursor Protein and Promotes Amyloidogenesis in Alzheimer's Disease

Δ-Secretase in Neurodegenerative Diseases: Mechanisms, Regulators and Therapeutic Opportunities

Beta-Secretase-1 Elevation In Transgenic Mouse Models Of Alzheimer'S Disease Is Associated With Synaptic/Axonal Pathology And Amyloidogenesis: Implications For Neuritic Plaque Development

Human beta-secretase and Alzheimer's disease

The Gamma-Secretase Complex: from Structure to Function

Β‐secretase‐1 Elevation in Transgenic Mouse Models of Alzheimer’s Disease is Associated with Synaptic/axonal Pathology and Amyloidogenesis: Implications for Neuritic Plaque Development

Alzheimer's Β-Secretase (BACE1) Regulates the Camp/pka/creb Pathway Independently of Β-Amyloid.

BACE1 SUMOylation Increases Its Stability and Escalates the Protease Activity in Alzheimer's Disease.